# Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)

> **NCT02302417** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1215 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **PROCEDURE:** Spirometry
- **OTHER:** ACOS clinical questionnaire

## Key facts

- **NCT ID:** NCT02302417
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2015-05-01
- **Final completion:** 2015-05-28
- **Target enrollment:** 1215 (ACTUAL)
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302417, "Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via MORVS 2026-10-09 from https://api.morvs.ai/clinical/NCT02302417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*